{
    "nctId": "NCT03730428",
    "briefTitle": "Everolimus Related Pneumonitis in MBC",
    "officialTitle": "Drug-related Pneumonitis During mTOR Inhibitor Therapy in Patients With Metastatic Breast Cancer: A Radiographic Patternbased Approach",
    "overallStatus": "COMPLETED",
    "conditions": "Everolimus, Pneumonitis",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 86,
    "primaryOutcomeMeasure": "radiographic pattern",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Postmenopausal woman (or premenopausal women treated with LHRHa) diagnosed with HR+\uff0cHER2- metastatic breast cancer\n2. Treated with everolimus for at least one month in metastatic setting\n3. With baseline and at least one follow-up chest CT during everolimus therapy.\n4. Complete medical history\n\nExclusion Criteria:\n\n1. Incomplete medical history\n2. Radiographic imaging unavailable",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}